Medigus Ltd. Series C Warrant
MDGSW
MDGSW was delisted on the 19th of July, 2023.
6 hedge funds and large institutions have $772K invested in Medigus Ltd. Series C Warrant in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
336% more capital invested
Capital invested by funds: $177K → $772K (+$595K)
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$265K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$330 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$8.44K |
MDGSW Hedge Fund Activity: Q3 2020 in Review
6 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Medigus Ltd. Series C Warrant (MDGSW) for Q3 2020, worth a combined $772K — up 336% from $177K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MDGSW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $265K. The largest seller was Sabby Management, cutting an estimated $8.44K.
- 6 institutional investors held Medigus Ltd. Series C Warrant (MDGSW) as of Q3 2020, up from 5 in Q2 2020.
- Funds reported $772K of Medigus Ltd. Series C Warrant stock for Q3 2020, up 336% quarter-over-quarter.
- 1 fund opened new Medigus Ltd. Series C Warrant positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest Medigus Ltd. Series C Warrant buyer in Q3 2020 was Armistice Capital, an estimated $265K added.
- The largest Medigus Ltd. Series C Warrant seller in Q3 2020 was Sabby Management, an estimated $8.44K sold.
Based on aggregated 13F filings for Q3 2020.